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Abstract
Cardiac dysrhythmia and sudden death account for a large proportion of cardiac mortality in dialysis patients. Risk factors 
for sudden death that are specific to dialysis patients include fluid and electrolyte imbalances during hemodialysis, particularly 
those of potassium. The risk of arrhythmia may be related to changes in serum K+ concentration during dialysis, and thus close 
attention should be paid to the dialysate K+ concentration and the serum–dialysate concentration gradient. Potassium profiling 
is a technique where the dialysate K+ concentration is gradually reduced to keep the gradient between blood and dialysate at a 
non-fluctuating low level. We provide a review of studies that compare constant potassium concentration in dialysate to gradual 
reduction in dialysate potassium concentration. These studies illustrate that adequate and more gradual potassium removal can 
be achieved with potassium profiling techniques, while having lower cardiac irritability.
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Introduction
Mortality and morbidity in End Stage Renal Disease 
(ESRD) patients on hemodialysis (HD) remains high, and 
higher than non-dialysis patients with similar co-morbidity 
burden (1). Cardiac dysrhythmia and sudden death account 
for a large proportion of  cardiac mortality in these patients, 
amounting to 26.9% of  total deaths (1). Risk factors for sud-
den death that are specific to dialysis patients include fluid 
and electrolyte imbalances during HD, particularly those 
of  potassium(K+) (2). Most of  the evidence linking the risk 
of  arrhythmia to dialysis is derived from Electrocardiogram 
(EKG) markers such as ventricular repolarization indices 
which include QT duration (QTc), QT dispersion (QTd), 
PCA-T (principal component analysis of  T wave), and 
E1-T (first eigenvalue of  T wave) (3–11). These indices are 
known to reflect increased risk of  arrhythmia (11, 12) and 
one of  the factors which has been shown to change these 
indices is the change in serum potassium, stemming from 
the critical role of  the K+ ion in myocardial repolarization 
(6, 13–15). Both hypokalemia and hyperkalemia have been 
shown to have associations with higher mortality in HD pa-
tients (16).
Due to lack of renal function to handle potassium 
 excretion, ESRD patients undergo potassium removal dur-
ing dialysis. In HD, this is achieved by diffusion of potassium 
from a higher concentration in serum to lower concentration 
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in dialysate, and is thus directly proportional to the concen-
tration gradient between blood and dialysate. Hyperkalemia 
is associated with higher mortality in dialysis patients (16) 
and high potassium concentration in dialysate might impair 
potassium removal. But at the same time, multiple studies 
have associated low dialysate potassium with higher risk of 
sudden cardiac death. It was noted in a study with the dialy-
sate K+ concentration of 0 and 1 meq/L (17), and with dial-
ysate K+ of less than 3 (18). Further, another study showed 
less arrhythmia when the K+ bath was 3.5 versus 2 (19). This 
may be related to rapid changes in serum potassium during 
dialysis, and the challenge is to balance adequate potassium 
removal with risk of arrhythmia while doing it.
Potassium profiling is a technique where the dialysate 
K+ concentration is gradually reduced to limit the gradi-
ent between blood and dialysate constant and low. It has 
the potential advantage of  reducing rapid changes in serum 
potassium level during dialysis (and thus reducing cardiac 
irritability), while also allowing for adequate potassium 
removal.
Here we provide a review of the randomized control tri-
als that have compared potassium profiling of dialysate to a 
fixed dialysate potassium concentration.
Methods
We searched the PubMed database using search terms “po-
tassium profiling,” “potassium profiling in hemodialysis,” 
“potassium hemodialysis,” and “dialysate potassium.” 
We included only the randomized control trials done in 
the past 25 years. The first study in our literature review 
to employ this technique was published in 1990 by Ebel et 
al. (20). Using a computerized program, they removed K+ 
slowly at a rate of  15%/hour and showed that incidence of 
arrhythmia was reduced from 60 to 25% (20). Since then, 
multiple randomized control trials have looked at potas-
sium profiling. Although they have used different profil-
ing techniques, all these studies have looked at effects of 
potassium profiling on cardiac stability using electrocar-
diographic markers and also ability to effectively remove 
potassium during dialysis.
Results
A brief  overview of these studies is provided in Table 1 
(21–26). All studies included in our review used a cross over 
design to compare constant potassium concentration in di-
alysate to gradual reduction in dialysate potassium concen-
tration. The number of subjects was small, ranging from 10 
to 36 patients. Inclusion and exclusion criteria were variable; 
some studies excluded patients with significant cardiovascu-
lar disease (3, 4), while others included only those who were 
considered high risk for arrhythmias (1, 6, 7). Although none 
of these studies looked exclusively at hyperkalemic patients, 
the average serum K+ concentration in these studies was nor-
mal or slightly high (up to 6 meq/L) and two studies excluded 
patients with hypokalemia (2, 6).
The dialysate potassium in control patients was mostly 
2 meq/L. The potassium profiling techniques used in 
study  population varied in different studies and are listed 
in Table 1.
A limitation of  these studies is that arrhythmic risk using 
indirect EKG and Holter markers was assessed rather than 
actual arrhythmia events. This relates to the rather small 
number of  study subjects and therefore the low overall inci-
dence of  arrhythmia. In the absence of  a unanimous EKG 
marker for predicting arrhythmia with changes in K+, in-
direct measures of  cardiac excitability and ventricular re-
polarization including Premature Ventricular Contractions 
(PVCs), changes in QTc/QTd/PCA-T/E1-T were used as 
surrogate markers of  arrhythmic risk. Lower cardiac irrita-
bility with potassium profiling was shown in all studies. The 
effects were generally more pronounced in patients who are 
at higher risk of  arrhythmia or who are dialysis sensitive. 
Comparison of  potassium removal with standard versus 
potassium profiled dialysate techniques was done by mea-
suring post-HD or pre-HD (prior to next session) serum 
potassium concentrations. There was no significant differ-
ence in these levels between the two techniques. Further, the 
training and technical requirements to implement this tech-
nique in a HD unit did not increase the work load of  the 
nephrologist or the nurses, nor did it increase the technical 
complexity (27).
Conclusion
There are no standard practices for dialysate potassium 
concentrations and no recommendation has been provided 
in the NKF-KDOQI (National Kidney Foundation–Kid-
ney Disease Outcomes Quality Initiative) cardiovascular 
disease guideline. In a large international cohort of  HD 
patients, dialysate potassium concentration varied among 
clinical practices and countries and ranged anywhere from 
1 meq/L to 3 meq/L (28). There are no large studies show-
ing a difference in clinically significant arrhythmic events 
when gradually removing potassium in dialysis patients via 
potassium profiling of  dialysate. However, there are mul-
tiple small studies suggesting a lower risk of  arrhythmia 
with potassium profiling by using indirect markers of  car-
diac excitability and ventricular repolarization. Also, these 
studies suggest that an adequate amount of  potassium 
could be removed without having a high gradient, at no 
extra financial cost. In our opinion, it would thus make 
sense to consider potassium profiling of  dialysate in HD 
patients to reduce cardiac irritability, especially in patients 
who are at higher risk.
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Redaelli (21) 36, RCT, 
Crossover
<3 mean 2.3 Serum K-1.5,b 
Reduce to K-2.5





Santoro (22) 10, RCT, 
Crossover
2 Serum K-1, Re-
duce to K-1.5
PVC, QTd, PCA-T, 
E1-T
No change in 
post-HD serum 
K levels




Severi (23) 10, RCT, 
Crossover
2 Serum K-0.5, 
Reduce to K-1.5
QTd, QRS dura-
tion, St depression, 
PCA-T, E1-T 





Santoro (24) 12, RCT, 
Crossover
2 Serum K-3.2-
4, Reduce to 
K-1-1.3
QTc, QTd, PVCs No change in 
post-HD K 
levels
Lesser change in 
QTc, reduce high 
grade PVCs
Santoro (25) 15, RCT, 
Crossover
2 Serum K-1, Re-
duce to K-1.5







Buemi (26) 24, RCT, 
Crossover
2 Serum K-1, 
Reduce to K-2
RBC REMP,c QTc, 
QTd




in QTc, QTd, 
REMP
Muñoz (27) 30, RCT, 
Crossover 
2.5 Serum K-0.5, 
Reduce to K-1.5






aControl bath = dialysate potassium fixed during the entire dialysis session (not profiled).
bStudy bath = potassium profiled bath. In this case, dialysate K concentration Kd = serum K – 1.5 meq/L.
cRed blood cell electrical membrane potential at rest (RBC REMP).
Premature ventricular contraction (PVC), QT duration (QTc), QT dispersion (QTd), principal component analysis of T wave 
(PCA-T), first eigenvalue of T wave (E1-T).
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